This topic contains a solution. Click here to go to the answer

Author Question: An entity that has subgroups of attributes violates Second Normal Form. Indicate whether the ... (Read 70 times)

iveyjurea

  • Hero Member
  • *****
  • Posts: 555
An entity that has subgroups of attributes violates Second Normal Form.
 
  Indicate whether the statement is true or false

Question 2

MIME is an extension to the ________ framework that is intended to address some of the problems and limitations of the use of SMTP.
 
  A. RFC 821 B. RFC 5322
 
  C. RFC 3852 D. RFC 4871



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

Sarahjh

  • Sr. Member
  • ****
  • Posts: 370
Answer to Question 1

TRUE

Answer to Question 2

B




iveyjurea

  • Member
  • Posts: 555
Reply 2 on: Jul 7, 2018
Thanks for the timely response, appreciate it


Jsherida

  • Member
  • Posts: 314
Reply 3 on: Yesterday
YES! Correct, THANKS for helping me on my review

 

Did you know?

You should not take more than 1,000 mg of vitamin E per day. Doses above this amount increase the risk of bleeding problems that can lead to a stroke.

Did you know?

Approximately one in three babies in the United States is now delivered by cesarean section. The number of cesarean sections in the United States has risen 46% since 1996.

Did you know?

Chronic necrotizing aspergillosis has a slowly progressive process that, unlike invasive aspergillosis, does not spread to other organ systems or the blood vessels. It most often affects middle-aged and elderly individuals, spreading to surrounding tissue in the lungs. The disease often does not respond to conventionally successful treatments, and requires individualized therapies in order to keep it from becoming life-threatening.

Did you know?

Anti-aging claims should not ever be believed. There is no supplement, medication, or any other substance that has been proven to slow or stop the aging process.

Did you know?

For high blood pressure (hypertension), a new class of drug, called a vasopeptidase blocker (inhibitor), has been developed. It decreases blood pressure by simultaneously dilating the peripheral arteries and increasing the body's loss of salt.

For a complete list of videos, visit our video library